Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Objective

In this study, quality of life and psychiatric comorbid disorders were investigated in patients with cervical dystonia and their spouses and we also investigated the effect of botulinum toxin (BTX) treatment on these parameters.

Material and method

Thirty patients with cervical dystonia (CD) on BTX treatment and their spouses (n = 30) were included. Beck Depression Scale (BDS), State-Trait Anxiety Inventory I and II (STAI-I, STAI-II), Hospital Anxiety Scale (HAS), Hospital Depression Scale (HDS) for psychiatric comorbid disease assessment, Toronto Western Spasmodic Torticollis Scale (TWSTRS) for disease activity assessment, and Craniocervical Dystonia Questionnaire (CDQ-24), Cervical Dystonia Impact Profile (CDIP-58), and Short Form 36 (SF-36) questionnaires for quality of life assessment were used. BDS, STAI-I and STAI-II, HAS, HDS, and SF-36 scales were also obtained from the spouses. The same tests were applied both before and 8 weeks after the BTX treatment.

Conclusion

In our study, an increase in psychiatric comorbid disorders such as depression and anxiety was observed and the quality of life was adversely affected in all areas in patients. In the spouses of the patients, the rates of psychiatric comorbid disorders such as depression and anxiety were found to be increased when compared to healthy subjects while vitality, mental health, and general health perception were found to be negatively affected.

Patients showed improvements in anxiety level, disease activity, and overall quality of life scales after BTX treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zurowski M, McDonald WM, Fox S, Marsh L (2013) Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord 28. https://doi.org/10.1002/mds.25501

  2. Fitzpatrick R (1992) “Quality of Life Measures in Health Care”, Applications and Issues in Assessement. BMJ 305:1074–1077

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Page D, Butler A, Jahanshahi M (2007) Quality of life in focal, segmental and generalized dystonia. Mov Disord 23(3):341–347

    Article  Google Scholar 

  4. Queiroz MR, Chien HF, Barbosa ER (2011) Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital. Arq Neuropsiquiatr 69:900–904

    Article  PubMed  Google Scholar 

  5. Ben-Shlomo Y, Camfield L, Warner T, on behalf of the ESDE collaborative group (2002) What are the determinants of quality of life in people with cervical dystonia. J Neurol Neurosurg Psychiatry 72:608–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Tepavcevic DK, Kostic VS (2009) Quality of life in patients with focal dystonia. Clin Neurol Neurosurg 111:161–164

    Article  PubMed  Google Scholar 

  7. Stamelou M, Edwards MJ, Hallett M, Bathia KP (2012) The non -motor syndrome of primary dystonıyia: clinical and pathophysiological implications. Brain 135:1668–1681

    Article  PubMed  Google Scholar 

  8. Akın YA, Akbostanci C, Mercan N, Aksun Z, Sorgun M (2012) Retrospective evaluation of 118 cervical dystonic cases treated with botulinum toxin Turk. J Neurol 18(3):104–107

    Google Scholar 

  9. Jog M, Chouinard S, Hobson D et al (2011) Causes for treatment delays in dystonia and Hemifacial spasm: a Canadian SurveyCan. J Neurol Sci 38:704–711

    Article  Google Scholar 

  10. Tomic S, Petkovic I, Pucic T, Resan B et al (2016) Cervical dystonia and quality of life. Acta Neurol Belg 116:589–592

    Article  PubMed  Google Scholar 

  11. Slawek J, Friedman A, Potulska A et al (2007) Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type a injections. Functl Neurol 22:95–100

    Google Scholar 

  12. Moraru E, Schnider P, Wimmer A, Wenzel T, Birner P, Griengl H et al (2002) Relation between depression and anxiety in dystonic patients: implications for clinical management. Depress Anxiety 16:100–103

    Article  CAS  PubMed  Google Scholar 

  13. Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, Diez J, Homann N, Wenning GK, Schnider P, Poewe W (2002) The Austrian botulinum toxin and dystonia study group. The impact of blepharospasm and cervical dystonia on health related quality of life and depression. J Neurol 249:842–846

    Article  CAS  PubMed  Google Scholar 

  14. Fabbri M, Superbo M, Defazio G, Scaglione CLM, Antelmi E, Basini G, Nassetti S, Pizza F, Plasmati R, Liguori R (2014) Quality of life in patients with craniocervical dystonia: Italian validation of the “cervical dystonia impact profile(CDIP-58)” and the “Craniocervical dystonia questionnaire (CDQ-24) ”. Neurol Sci 35:1053–1058

    Article  PubMed  Google Scholar 

  15. Lim VK (2007) Health related quality of life in patients with dystonia and tehir caregivers in new Zeland and Australia. Mov Disord 22(7):998–1003

    Article  PubMed  Google Scholar 

  16. Wollmer MA, Boer C, Kalak N et al (2012) Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res 46:574–581

    Article  PubMed  Google Scholar 

  17. Kocaman G, Baslo MH, Hanağası H, Parman Y. İdyopatik servikal distonili hastalarda botulinum toksini uygulanmasından önce ve sonra kas aktivasyon paterninde görülen değişimlerin incelenmesi Nöropsikiyatri Arflivi 2009; 46: 39–43

  18. Fabbrini G, Berardelli I, Moretti G, Pasquini M, Bloise M, Colosimo C et al (2010) Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 25:459–465

    Article  PubMed  Google Scholar 

  19. Hefter H, Benecke R, Erbguth F, Jost W, Reichel G, Wissel J (2013) An open label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin a (Dysport). BMJ Open 3:e0011853. https://doi.org/10.1136/bmjopen-2012-001853

    Article  Google Scholar 

  20. Jen MH, Kurth H (2014) Assessing the burden of illness from cervical dystonia using the Toronto Western spasmodic torticollis rating scale scores and health utility: a meta- analysis of baseline patient-level clinical trial data. J Med Econ 17(11):803–809

    Article  PubMed  Google Scholar 

Download references

Funding

This research did not receive any grants or funding from any funding agencies. The authors have no funding to report.

Author information

Authors and Affiliations

  1. Medical Faculty, Department of Neurology, Department of Neurology, Uludag University, 16059 Gorukle, Bursa, Turkey

    Dursun Ceylan, Sevda Erer, Mehmet Zarifoğlu & Nevin Türkeş

  2. Medical Faculty, Department of Biostatistics, Uludag University, Bursa, Turkey

    Güven Özkaya

Authors
  1. Dursun Ceylan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sevda Erer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehmet Zarifoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nevin Türkeş
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Güven Özkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sevda Erer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ceylan, D., Erer, S., Zarifoğlu, M. et al. Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives. Neurol Sci 40, 725–731 (2019). https://doi.org/10.1007/s10072-019-3719-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-3719-9

Keywords

Search

Navigation